TELEPROM Psoriasis: Enhancing patient-centered care and health-related quality of life (HRQoL) in moderate-to-severe plaque psoriasis
This study demonstrates the efficacy of biologic treatments in significantly improving HRQoL for psoriasis patients. Addressing demographic variables, such as gender, is key for optimizing treatment outcomes and improving ePROMs response rates. Tailored strategies and ML techniques can help identify low-engagement patients and mitigate disparities. Integrating sociodemographic factors into clinical decision-making and patient engagement strategies is fundamental for delivering equitable and comprehensive care.
Authors
- Álvaro Alonso (ORCID: https://orcid.org/0000-0002-2225-8323)
- Emilio Monte‐Boquet (ORCID: https://orcid.org/0000-0001-5352-2601)
- Salvador Herrera-Pérez
- Núria Padullés Zamora (ORCID: https://orcid.org/0000-0002-8783-3042)
- Patricia Sanmartín-Fenollera (ORCID: https://orcid.org/0000-0002-5944-9182)
- Olatz Ibarra Barrueta (ORCID: https://orcid.org/0000-0003-0852-5496)
- M Martínez (ORCID: https://orcid.org/0009-0008-3693-9980)
- Gabriel Mercadal-Orfila (ORCID: https://orcid.org/0000-0001-7304-458X)
- Joaquín Borrás Blasco
- Cristina C. Montes
- Piedad López Sánchez
Institutions
- Valencian International University (ES)
- Bellvitge University Hospital (ES)
- Hospital Universitari i Politècnic La Fe (ES)
- Hospital Universitari Sant Joan D'Alacant (ES)
- Hospital Universitario Fundación Alcorcón (ES)
- Hospital General de Tomelloso (ES)
- Hospital de Galdakao (ES)
- Hospital General Mateu Orfila (ES)
- Hospital Universitario del Sureste (ES)
- Hospital de Sagunto (ES)
- Hospital Universitario de Fuenlabrada (ES)
- Universitat de les Illes Balears (ES)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2024-12-10
- DOI
- https://doi.org/10.3389/fmed.2024.1465725
- Citations
- 4
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 0.96
Funders
- Sociedad Española de Farmacia Hospitalaria